Evidence map›Paper›PMID 34255587›Full record

ArticleOcular immunology and inflammation2021

Endogenous Endophthalmitis A Complication of COVID-19 Pandemic: A Case Series.

Manisha Agarwal, Mani Sachdeva, Surendra Pal, Harita Shah, Madhu Kumar R, Alay Banker

Abstract readCase ReportsMulticenter Study
PubMed Publisher
In one paragraph

Article in Ocular immunology and inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Endogenous Endophthalmitis Caused byTurkish journal of ophthalmology · 2024
    Article
  4. Article
  5. [Endogenous Candida endophthalmitis].Die Ophthalmologie · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Endogenous endophthalmitis due to methicillin-resistantProceedings (Baylor University. Medical Center) · 2022
    Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Manisha AgarwalVitreoretina Department, Dr Shroff's Charity Eye Hospital, New Delhi, India.
Mani SachdevaVitreoretina Department, Dr Shroff's Charity Eye Hospital, New Delhi, India.
Surendra PalVitreoretina department, Sankara Eye Hospital, Bengaluru, India.
Harita ShahVitreoretinal department, Banker's Retina Clinic & Laser Centre, Ahmedabad, India.
Madhu Kumar RVitreoretina department, Sankara Eye Hospital, Guntur, India.
Alay BankerVitreoretinal department, Banker's Retina Clinic & Laser Centre, Ahmedabad, India.
Dr. Shroff’s Charity Eye Hospital · INEye Hospital in Bangalore · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report six patients with endogenous endophthalmitis as a complication of COVID-19 infection.

methodsA multicentric retrospective database review of patients with a diagnosis of endogenous endophthalmitis and a history of COVID-19 infection.

results

conclusionsCOVID-19 patients with a history of hospitalization and prolonged use of systemic corticosteroids and comorbidities, for example, diabetes mellitus have a high risk of endogenous endophthalmitis. A high index of clinical suspicion with timely intervention can salvage many eyes.

Indexed as

PandemicsVisual AcuityAdultBacteriaCOVID-19EndophthalmitisEye Infections, BacterialEye Infections, FungalFollow-Up StudiesFungiHumansIndiaMaleMiddle AgedRetrospective StudiesVitreous BodycorticosteroidsCOVID-19Endogenous endophthalmitisimmunocompromised

Identifiers

PMID34255587
OpenAlexW3178745740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.